Results 161 to 170 of about 8,404 (212)

Aminolevulinate inhibition of human coproporphyrinogen oxidase clarifies coproporphyrin III accumulation in porphyrias. [PDF]

open access: yesBiosci Rep
Schedlbauer A   +9 more
europepmc   +1 more source

From photosensitivity to autoimmunity: the role of AI metabolomics in PCT-celiac disease overlap. [PDF]

open access: yesAnn Med Surg (Lond)
Ozukum ST   +4 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Acute Intermittent Porphyria

Seminars in Liver Disease, 1998
Acute intermittent porphyria (AIP) is transmitted as an autosomal dominant disorder with incomplete penetrance. Recent population studies suggest that the prevalence of asymptomatic heterozygotes for a mutant AIP gene may be in the range of 1 in 2,000. Clinical manifestations include abdominal pain and neurological dysfunctions.
Bernard Grandchamp
exaly   +3 more sources

The acute porphyrias

The Lancet, 1997
Public attention has been drawn to the acute porphyrias in the past few years by speculation that they affected the character of George III and the creative genius of Vincent van Gogh. During the same period, there have been important advances in the understanding of the molecular basis of the acute porphyrias and in diagnosis and the clinical ...
G H, Elder, R J, Hift, P N, Meissner
openaire   +2 more sources

Acute Porphyrias

The Journal of Emergency Medicine, 2015
Porphyrias are a group of eight metabolic disorders characterized by defects in heme biosynthesis. Porphyrias are classified into two major categories: 1) the acute or inducible porphyrias and 2) the chronic cutaneous porphyrias. The acute hepatic porphyrias are further classified into acute intermittent porphyria (AIP), hereditary coproporphyria ...
Siddesh, Besur   +2 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy